The current state of endovascular therapy in the evaluation and management of renovascular disease

Praveen R. Anchala, Scott A. Resnick

Research output: Contribution to journalArticlepeer-review


Hypertension is the most common reason for physician office visits among nonpregnant adults in the United States; up to one-third of Americans over the age of 18 have been diagnosed with hypertension. Patients with physiologically significant renal artery stenosis often go unnoticed because hypertension can often be well controlled with antihypertensive medications. As a result, screening for renovascular causes of hypertension is rarely done. However, the likelihood of renovascular disease increases in patients with acute, severe, or refractory hypertension and should be explored in patients who fall into these categories. Renovascular disease is a crucial consideration in the management of hypertension due to its increasing incidence and its potential for reversibility. Although renovascular disease accounts for less than 1% of patients with mild hypertension, it is estimated that between 10 and 45% of white patients with severe or malignant hypertension have renal artery stenosis (RAS). In this population, diagnosing and treating RAS can have a profound and long-lasting effect on the treatment of hypertension.

Original languageEnglish (US)
Pages (from-to)333-344
Number of pages12
JournalSeminars in Interventional Radiology
Issue number4
StatePublished - 2009


  • Hypertension
  • angioplasty
  • atherosclerosis
  • fibromuscular dysplasia
  • renovascular hypertension

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The current state of endovascular therapy in the evaluation and management of renovascular disease'. Together they form a unique fingerprint.

Cite this